Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, Germany
Their stated focus (public profile)
Boehringer Ingelheim Venture Fund invests in pioneering science aimed at redefining the standard of care and bringing new medicines to patients. The fund focuses on first-in-class, disease-modifying therapeutics across various modalities, with a portfolio spanning anti-infectives, auto-immunity, oncology, regenerative medicine, and digital health. Active since 2010, it has invested in over 70 companies and select fund-in-fund opportunities globally across the EU, US, and China.
Sectors: Life sciences, Healthtech
On file: 13 partners on record · 40 companies on record
Website: boehringer-ingelheim-venture.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.